Epigenomic and phenotypic characterization of DEGCAGS syndrome
- PMID: 39424669
- PMCID: PMC11606972
- DOI: 10.1038/s41431-024-01702-y
Epigenomic and phenotypic characterization of DEGCAGS syndrome
Abstract
Developmental Delay with Gastrointestinal, Cardiovascular, Genitourinary, and Skeletal Abnormalities syndrome (DEGCAGS, MIM #619488) is caused by biallelic, loss-of-function (LoF) ZNF699 variants, and is characterized by variable neurodevelopmental disability, discordant organ anomalies among full siblings and infant mortality. ZNF699 encodes a KRAB zinc finger protein of unknown function. We aimed to investigate the genotype-phenotype spectrum of DEGCAGS and the possibility of a diagnostic DNA methylation episignature, to facilitate the diagnosis of a highly variable condition lacking pathognomonic clinical findings. We collected data on 30 affected individuals (12 new). GestaltMatcher analyzed fifty-three facial photographs from five individuals. In nine individuals, methylation profiling of blood-DNA was performed, and a classification model was constructed to differentiate DEGCAGS from controls. We expand the ZNF699-related molecular spectrum and show that biallelic, LoF, ZNF699 variants cause unique clinical findings with age-related presentation and a similar facial gestalt. We also identified a robust episignature for DEGCAGS syndrome. DEGCAGS syndrome is a clinically variable recessive syndrome even among siblings with a distinct methylation episignature which can be used as a screening, diagnostic and classification tool for ZNF699 variants. Analysis of differentially methylated regions suggested an effect on genes potentially implicated in the syndrome's pathogenesis.
© 2024. The Author(s), under exclusive licence to European Society of Human Genetics.
Conflict of interest statement
Competing interests: BS is a shareholder in EpiSign Inc, company involved in commercialization of EpiSignTM technology. Ethical approval: This study was performed according to the Declaration of Helsinki and approved by the Western Norway Regional Ethics Committee (REC 604007) and the Western Ontario University Research Ethics Board (REB 106302). Written informed consent for the publication of photographs, videos and medical information was obtained from parents/legal guardians.
References
-
- Rosspopoff O, Trono D. Take a walk on the KRAB side: (Trends in Genetics, 39:11 p:844-57, 2023). Trends Genet. 2023. - PubMed
MeSH terms
Substances
Grants and funding
- DK068306/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- 281319475/Deutsche Forschungsgemeinschaft (German Research Foundation)
- R01HG009141/U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI)
- R01 HG009141/HG/NHGRI NIH HHS/United States
- R01 DK068306/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources